Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma

Stopped early · Phase 2

Conditions studied: Multiple Myeloma

In brief

Purpose: The purpose of this study is to see if TBL 12, which is a blend of Sea Cucumber, Sea Sponge, Shark Fin, and Sea Urchin (animals that live in the Pacific Ocean) as well as Sargassum (a plant that lives in the Pacific Ocean), will have effects against asymptomatic multiple myeloma and to see what the side effects are. Eligibility: Several criteria must be met to be eligible for this study, including but not limited to the following: * a diagnosis of asymptomatic multiple myeloma * adequate cardiac, liver and kidney function * age 18 and older

Key facts

Study ID

NCT01096810

Run by

Jagannath, Sundar, M.D.

People needed

20

Starts

2008-09-01

Expected to finish

2014-03-01

Last updated by the study team

2016-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of multiple myeloma
• Measurable disease
• For non-secretors, measurable protein by Freelite or plasmacytoma
• Asymptomatic disease

You may not qualify if…

• POEMS syndrome
• Plasma cell leukemia
• Receiving steroids greater than the equivalent of 10 mg prednisone
• Infection not controlled by antibiotics
• HIV infection
• Known active hepatitis B or C

Where it is running

• Mount Sinai Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.